pfe stock dividend Complete Guide

Pfizer (PFE) Stock Dividend

Quick summary: The pfe stock dividend is Pfizer Inc.'s quarterly cash dividend paid on common stock and serves as an income component for many investors. As of Jan 15, 2026, Pfizer continued to declare quarterly dividends subject to Board approval; readers should verify current amounts and dates from official company releases and broker feeds.

Overview

The pfe stock dividend refers to the quarterly cash dividend Pfizer Inc. (NYSE: PFE) pays on its common shares when declared by the Board of Directors. The dividend process follows standard U.S. corporate mechanics: the Board declares a dividend (declaration date), the market sets an ex-dividend date that determines who is eligible, a record date identifies shareholders on Pfizer's books, and a payable date when Pfizer transfers cash to holders of record.

As of Jan 15, 2026, according to Pfizer investor relations and major market-data providers, the most recently declared quarterly dividend was approximately $0.43 per share, annualizing to roughly $1.72 per share; the headline dividend yield reported by public sources was in the mid-single-digit to high-single-digit range depending on share price and data provider. All dividend payments remain subject to Board approval and can change if Pfizer's Board elects to adjust payout policy.

Note: the exact pfe stock dividend amount, ex-dividend date, and yield change over time. Always confirm with Pfizer press releases, SEC filings, or your brokerage for up-to-date values.

History

Pfizer has a long history of paying dividends, spanning multiple decades. The company has generally maintained a consistent quarterly cash dividend policy and has increased its dividend in several periods — reflecting Pfizer's position as a large-cap pharmaceutical company with established, diversified cash flows.

Public data services archive Pfizer's historical dividend amounts and dates, showing a record of dividend declarations, occasional increases, and adjustments tied to corporate actions. For example, over multiyear windows Pfizer has both raised its quarterly payout and, in some years, maintained stable payments while deploying capital to acquisitions, buybacks, and R&D. Historical details for the pfe stock dividend — including past quarterly amounts, declaration dates, and payable schedules — are available through Pfizer's investor relations dividend & split history and via market-data vendors that track dividend series.

Recent Dividend Amounts and Schedule

Below is a concise summary of the recent pattern for the pfe stock dividend. (Readers: verify current amounts with the company's latest announcements.)

• Typical recent quarterly amount: $0.43 per share (example recent figure that annualizes to $1.72 per share).
• Annualized dividend: approximately $1.72 per share using the above quarterly figure.
• Typical payment cadence: Pfizer historically declares a quarterly dividend and sets ex-dividend, record and payable dates spaced roughly one to two months apart, often aligning payments to a quarterly calendar.

As of Jan 15, 2026, Pfizer's most recent public dividend declaration followed the standard cadence: a declaration announcement, an ex-dividend date approximately 2–4 weeks before the payable date, and payment to registered shareholders on the payable date. The spacing of these dates has been consistent in recent years, with ex-dividend dates commonly falling one to two weeks after the declaration or within the same quarter. For precise ex-dividend/record/payable dates for the pfe stock dividend, consult the company's dividend press release and the dividend & split history table.

Key Dividend Metrics

Investors use several metrics to evaluate the pfe stock dividend and dividend income relative to other opportunities. Common metrics include:

• Dividend yield: annual dividend per share divided by current share price. This reflects current income relative to price and swings with market moves.
• Payout ratio: dividends paid divided by reported earnings (or adjusted EPS) — a gauge of how much profit is returned to shareholders as dividends.
• Annual dividend per share: sum of quarterly dividends over the most recent 12 months.
• Dividend growth rates: year-over-year or compound annual growth rates (CAGR) over 1-, 3-, 5-, and 10-year periods.
• Shareholder yield: cash returned to shareholders via dividends plus net buybacks, offering a fuller view of capital returned.

Typical reported ranges: headline dividend yield for Pfizer has commonly been in the mid-to-high single digits depending on share price movements; payout ratios have, at times, appeared elevated (near or above ~90% on certain GAAP basis reports) after years with compressed earnings or one-time charges. Metrics change with earnings, one-off items, and market pricing, so interpret them using multiple measures (GAAP vs. adjusted earnings, free cash flow payout, and shareholder yield) for a clearer picture of dividend sustainability.

Dividend Yield

Dividend yield for the pfe stock dividend is calculated as annual dividends per share divided by the current market price per share. For example, if the annualized dividend equals $1.72 and the share price is $30, the yield = 1.72 / 30 = 5.73%.

Because the yield uses current price in the denominator, the pfe stock dividend yield fluctuates with daily share-price movements even when the dividend payment itself is fixed for the declared period. Market-data providers publish current yields; as of Jan 15, 2026, public sources indicated a yield in the mid-to-high single-digit range, varying by data vendor and the share-price snapshot used.

Payout Ratio and Dividend Sustainability

The payout ratio measures the portion of earnings (or adjusted earnings/free cash flow) paid out as dividends. A high payout ratio (for example, near or above ~90–100% on a GAAP EPS basis) could signal limited room for growth in the dividend if earnings weaken, while a relatively lower payout ratio indicates more cushion.

For the pfe stock dividend, reported payout ratios have varied depending on whether analysts use GAAP EPS, adjusted EPS (which excludes certain one-time items), or free cash flow. In years with weaker reported earnings or large charges, the GAAP payout ratio can temporarily appear very high. Sustainability depends on Pfizer's cash flow generation, pipeline outlook, capital allocation priorities (acquisitions vs. dividends vs. buybacks), and the Board's decisions. Historical dividend increases and a long history of payments are supportive signals, but they do not guarantee future increases.

Governance and Declaration Process

Dividends are declared by Pfizer's Board of Directors. The governance process typically follows this sequence:

• Board meeting and declaration: Pfizer's Board reviews cash flow, capital needs, and strategic priorities before declaring a dividend.
• Public announcement: Pfizer issues a press release and files required SEC disclosures specifying the declaration date, dividend amount, ex-dividend date, record date, and payable date.
• Ex-dividend and record processing: broker systems process ex-dividend and record dates; shareholders holding common stock before the ex-dividend date are eligible.

Announcements concerning the pfe stock dividend are communicated via Pfizer press releases and company SEC filings. Institutional investors and retail brokers watch these releases closely for timing and amount.

Qualification and Tax Treatment

For U.S. taxpayers, dividends paid on common stock may be "qualified" dividends if certain holding-period requirements are met, which typically results in lower federal tax rates than ordinary income rates. The pfe stock dividend is generally treated as qualified for U.S. taxpayers if the investor meets the holding-period rules and other IRS requirements.

Non-U.S. holders may face withholding taxes or different treatments depending on tax treaties and local rules. Because tax consequences vary by jurisdiction and individual circumstances, consult a tax professional for specific guidance on the tax treatment of the pfe stock dividend.

How Investors Receive Dividends

Retail and institutional shareholders receive the pfe stock dividend through common mechanisms:

• Brokerage accounts: most retail investors receive cash dividend payments directly into their brokerage accounts on the payable date.
• Registered holders: investors who hold shares directly on Pfizer's registry receive payments by check or electronic transfer per the company's registry processes.
• Dividend reinvestment plans (DRIPs): many brokers offer automatic reinvestment of cash dividends into additional shares. Check with your broker to enable or configure DRIP options for the pfe stock dividend.

To be eligible for a dividend payment, an investor must hold Pfizer common shares prior to the ex-dividend date. Buying on or after the ex-dividend date typically results in missing that dividend's entitlement.

Investment Considerations and Risks

Why investors consider the pfe stock dividend

• Income: Pfizer's quarterly cash dividend provides a recurring income stream for yield-oriented investors.
• Large-cap stability: as a diversified, well-established pharmaceutical company, Pfizer offers exposure to defensive healthcare revenue that may be less cyclical than other sectors.
• Total-return potential: together with buybacks and business growth, dividends are part of Pfizer's capital-return framework.

Risks that affect dividend safety and outlook

• Earnings volatility: product sales, patent expiries, or temporary write-downs can compress earnings and increase payout ratios.
• Regulatory, pricing, and reimbursement pressure: drug pricing dynamics and regulatory outcomes can materially influence future cash flows.
• Pipeline and product concentration: setbacks in key products or patent cliffs may reduce revenue.
• Capital allocation choices: management may prioritize acquisitions or reinvestment over dividends, or vice versa, depending on strategy.
• One-time charges: large impairment charges or restructuring can distort GAAP earnings and temporarily raise payout ratios.

Importantly, dividends are not guaranteed and are subject to Board discretion. Historical payments do not ensure future distributions of the pfe stock dividend.

Typical Income Strategies Involving PFE

Investors use several common strategies with Pfizer to target income or total return:

• Long-term income holding: buy-and-hold investors who value steady cash payments may include Pfizer as a core dividend name.
• Covered-call overlays: selling call options against Pfizer shares can boost income but caps upside and introduces option risk.
• Dividend-capture caution: short-term tactics that buy before ex-dividend dates to capture payouts often ignore transaction costs, tax consequences, and price adjustments; many investors favor total-return approaches instead.

Across strategies, investors should weigh dividend yield against fundamentals, payout metrics, and overall portfolio diversification.

Historical Data and Sources

Authoritative places to find historical data on the pfe stock dividend include:

• Pfizer — Dividend & Split History (Pfizer investor relations provides a table of historical declaration dates, ex-dividend dates, record dates, payable dates, and amounts).
• Pfizer press releases that announce each dividend declaration and provide context for the Board's decision.
• SEC filings where Pfizer discloses relevant corporate events and fiscal context.
• Reputable market-data vendors and dividend trackers that compile historical tables and calculate metrics like trailing yield, payout ratio, and growth rates.

These sources provide comprehensive historical tables listing each pfe stock dividend payment and associated dates for investor verification.

Comparison with Peers

When comparing the pfe stock dividend to peers in large-cap pharma and healthcare, consider multiple dimensions:

• Yield: compare current dividend yield with other large pharma companies.
• Payout ratio: evaluate whether Pfizer returns a larger or smaller share of earnings via dividends compared with peers.
• Dividend growth: measure how aggressively each company has increased dividends over time.
• Shareholder yield: include buybacks to see total cash returned to investors.

Sector-specific factors matter: patent expiries, pipeline robustness, and product concentration can drive differences between Pfizer and peers. A higher yield may reflect market concerns about growth or earnings rather than an undervaluation.

Frequently Asked Questions (FAQ)

Q: When is the next ex-dividend date for the pfe stock dividend? A: Dividend dates change with each declaration. As of Jan 15, 2026, the best way to confirm the next ex-dividend date is to check Pfizer's latest press release or your brokerage's dividend calendar.

Q: How much is the current quarterly dividend for PFE? A: As of Jan 15, 2026, public reporting identified a recent quarterly payout of approximately $0.43 per share. Confirm with Pfizer's latest declaration for an exact current amount.

Q: Is Pfizer a dividend aristocrat? A: "Dividend aristocrat" status depends on specific index rules (e.g., S&P 500 dividend aristocrats require 25+ consecutive years of increases). Pfizer has a long history of dividends and periodic increases, but whether it meets a particular aristocrat list depends on the list's criteria and current history; check specific index definitions and current constituent lists for verification.

Q: How can I receive the pfe stock dividend if I use Bitget Wallet or Bitget brokerage services? A: If you hold Pfizer shares via a broker that supports U.S. equities and dividend crediting, dividends are typically credited to your brokerage account on the payable date. If you hold fractional or whole shares via a custody service integrated with Bitget services that provide equities (confirm product availability), follow the platform's instructions for settlement and dividend handling. For holdings in non-broker custody (e.g., direct registration), consult your registry statement for payment method and timing.

References and External Links

Sources for historical verification and up-to-date figures include Pfizer investor relations (dividend & split history), Pfizer press releases for each dividend declaration, SEC filings, and major market-data providers that track PFE dividend history and metrics. Example vendor names that commonly publish dividend tables and metrics include well-known market-data platforms and dividend-tracking services.

Note: figures and dates change over time. As of Jan 15, 2026, figures cited in this article reflect the most-recent public reporting available at that date. Always verify current values with Pfizer's investor-relations releases or your brokerage.

Appendix: Sample Historical Dividend Table Structure

Below is a sample table structure investors can expect when reviewing historical records for the pfe stock dividend. (This is a template; actual historical entries should be obtained from Pfizer's dividend history page.)

| Declaration Date | Ex-Dividend Date | Record Date | Payable Date | Amount (per share) | Type | | --- | --- | --- | --- | ---: | --- | | YYYY-MM-DD | YYYY-MM-DD | YYYY-MM-DD | YYYY-MM-DD | $0.43 | Cash |

How to interpret each column:

• Declaration Date: when the Board announces the dividend and specifies dates and amount.
• Ex-Dividend Date: the first date on which new buyers of the stock are not entitled to the declared dividend.
• Record Date: the cut-off date at which shareholders of record are identified for payment.
• Payable Date: the date cash is distributed to holders of record.
• Amount: cash per share for that dividend.
• Type: usually "Cash" for ordinary dividends; occasional entries may show special dividends or other corporate distributions.

Additional Practical Notes for Investors

• Monitor company announcements: since dividends are Board-determined, keep an eye on Pfizer press releases around typical declaration windows.
• Use multiple metrics: evaluate dividend yield alongside payout ratio, adjusted earnings, and free cash flow to more reliably assess sustainability of the pfe stock dividend.
• Consider taxes and account type: dividend net pay depends on whether shares are held in taxable accounts, tax-advantaged accounts, or involve foreign withholding for non-U.S. holders.
• Total-return focus: income investors should balance yield with business fundamentals, pipeline prospects, and capital-return policies.

Further explore how dividends fit within your broader portfolio goals and how brokerage features like automatic reinvestment can change your cash-flow and compounding outcomes. For custody, trading, or wallet solutions related to diversified asset management, consider Bitget's product offerings and Bitget Wallet for integrated asset access and custody features.

Reporting Date and Data Context

As of Jan 15, 2026, according to Pfizer investor relations and public market-data providers, the most recent declared quarterly payout approximated $0.43 per share and market-data snapshots placed Pfizer's market capitalization in the hundreds of billions of dollars with average daily trading volume in the multi-million-share range. Readers should treat these figures as time-stamped estimates and verify the current pfe stock dividend values and market metrics from Pfizer's investor-relations releases and broker quotes.

Further exploration: review Pfizer's dividend & split history and recent press releases to confirm the latest pfe stock dividend amount and dates. If you use Bitget services, check product availability and settlement options for U.S. equities and dividend crediting.